Search research articles
Contact Us
Filters
Showing results (51-60 of 128) with videos related to
Page
of 13
Sort By:
Cancer Genomics & Proteomics
|
June 3, 2009
Proteomic analysis of archival breast cancer serum
Bashar A Zeidan, Ramsey I Cutress, Nick Murray, et al.
Urology
|
November 21, 2017
Epidermal Growth Factor Receptor Family Inhibition Identifies P38 Mitogen-activated Protein Kinase as a Potential Therapeutic Target in Bladder Cancer
Regina Mora Vidal, Sergio Regufe da Mota, Annette Hayden, et al.
RSC Advances
|
February 20, 2018
High throughput imaging cytometer with acoustic focussing
Robert Zmijan, Umesh S Jonnalagadda, Dario Carugo, et al.
Expert Reviews in Molecular Medicine
|
March 23, 2004
BAG-1 in carcinogenesis
Adam Sharp, Simon J Crabb, Paul A Townsend, et al.
Bioorganic & Medicinal Chemistry
|
March 23, 2011
Total synthesis of largazole and analogues: HDAC inhibition, antiproliferative activity and metabolic stability
Hanae Benelkebir, Sabrina Marie, Annette L Hayden, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
August 20, 2009
Thioflavin S (NSC71948) interferes with Bcl-2-associated athanogene (BAG-1)-mediated protein-protein interactions
Adam Sharp, Simon J Crabb, Peter W M Johnson, et al.
Bioorganic & Medicinal Chemistry
|
March 9, 2011
Enantioselective synthesis of tranylcypromine analogues as lysine demethylase (LSD1) inhibitors
Hanae Benelkebir, Christopher Hodgkinson, Patrick J Duriez, et al.
Urologic Oncology
|
May 20, 2014
The Nrf2 transcription factor contributes to resistance to cisplatin in bladder cancer
Annette Hayden, James Douglas, Matthew Sommerlad, et al.
Experimental Cell Research
|
July 31, 2007
Subcellular localisation of BAG-1 and its regulation of vitamin D receptor-mediated transactivation and involucrin expression in oral keratinocytes: implications for oral carcinogenesis
San San Lee, Simon J Crabb, Nari Janghra, et al.
British Journal of Haematology
|
June 15, 2006
The anti-CD20 antibody rituximab augments the immunospecific therapeutic effectiveness of an anti-CD19 immunotoxin directed against human B-cell lymphoma
David J Flavell, Sarah L Warnes, Christine J Bryson, et al.
Page
of 13
Search research articles
Search
Showing results (51-60 of 128) with videos related to
Sort By:
Page
of 13
Cancer Genomics & Proteomics
|
June 3, 2009
Proteomic analysis of archival breast cancer serum
Bashar A Zeidan, Ramsey I Cutress, Nick Murray, et al.
Urology
|
November 21, 2017
Epidermal Growth Factor Receptor Family Inhibition Identifies P38 Mitogen-activated Protein Kinase as a Potential Therapeutic Target in Bladder Cancer
Regina Mora Vidal, Sergio Regufe da Mota, Annette Hayden, et al.
RSC Advances
|
February 20, 2018
High throughput imaging cytometer with acoustic focussing
Robert Zmijan, Umesh S Jonnalagadda, Dario Carugo, et al.
Expert Reviews in Molecular Medicine
|
March 23, 2004
BAG-1 in carcinogenesis
Adam Sharp, Simon J Crabb, Paul A Townsend, et al.
Bioorganic & Medicinal Chemistry
|
March 23, 2011
Total synthesis of largazole and analogues: HDAC inhibition, antiproliferative activity and metabolic stability
Hanae Benelkebir, Sabrina Marie, Annette L Hayden, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
August 20, 2009
Thioflavin S (NSC71948) interferes with Bcl-2-associated athanogene (BAG-1)-mediated protein-protein interactions
Adam Sharp, Simon J Crabb, Peter W M Johnson, et al.
Bioorganic & Medicinal Chemistry
|
March 9, 2011
Enantioselective synthesis of tranylcypromine analogues as lysine demethylase (LSD1) inhibitors
Hanae Benelkebir, Christopher Hodgkinson, Patrick J Duriez, et al.
Urologic Oncology
|
May 20, 2014
The Nrf2 transcription factor contributes to resistance to cisplatin in bladder cancer
Annette Hayden, James Douglas, Matthew Sommerlad, et al.
Experimental Cell Research
|
July 31, 2007
Subcellular localisation of BAG-1 and its regulation of vitamin D receptor-mediated transactivation and involucrin expression in oral keratinocytes: implications for oral carcinogenesis
San San Lee, Simon J Crabb, Nari Janghra, et al.
British Journal of Haematology
|
June 15, 2006
The anti-CD20 antibody rituximab augments the immunospecific therapeutic effectiveness of an anti-CD19 immunotoxin directed against human B-cell lymphoma
David J Flavell, Sarah L Warnes, Christine J Bryson, et al.
Page
of 13